Condition
Hypopharynx Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hypopharynx Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Netherlands (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Sacituzumab govitecan plus cetuximab for recurrent or metastatic head and neck squamous cell cancer
This trial will test whether combining sacituzumab govitecan with cetuximab works and is safe for people whose head and neck squamous cell cancer has returned or spread after prior immunotherapy.
-
Personalized neck irradiation for head and neck cancer based on lymph node biopsy results
This study is testing if using biopsy results to personalize neck radiation can help people with laryngeal and pharyngeal cancer avoid unnecessary treatment and improve their quality of life.
Related topics
Quick answers
How many Hypopharynx Squamous Cell Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.